ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
Abstract Apolipoprotein CIII (apoCIII) has been reported to be tightly associated with triglyceride metabolism and the susceptibility to coronary artery disease (CAD). Besides, apoCIII has also been found to affect the anti-apoptotic effects of HDL. However, the effect of apoCIII on HDL-mediated cho...
Guardado en:
Autores principales: | Mengdie Luo, Aiying Liu, Shuai Wang, Tianle Wang, Die Hu, Sha Wu, Daoquan Peng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eeb2a44dbea143e8b008f8f207707678 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The association between impairment of HDL cholesterol efflux capacity and atrial remodeling in atrial fibrillation
por: Asuka Minami-Takano, et al.
Publicado: (2021) -
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
por: Reza Fadaei, et al.
Publicado: (2018) -
HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial
por: Ruth Blanco-Rojo, et al.
Publicado: (2017) -
Association of proportion of the HDL-cholesterol subclasses HDL-2b and HDL-3 and macrovascular events among patients undergoing hemodialysis
por: Wen-Chin Lee, et al.
Publicado: (2021) -
Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease
por: William Hancock-Cerutti, et al.
Publicado: (2021)